The IRB Examined

Research involving human participants is not a niche activity. It encompasses clinical trials testing new medications, sociological surveys about poverty and inequality, psychological experiments on memory and decision-making, ethnographic fieldwork in communities, and online studies analyzing social behavior. Across all of these domains, the Institutional Review Board functions as the primary institutional mechanism for ensuring that participants are protected from harm. The scale of that responsibility is enormous, and it is easy to underestimate.

Consider what happens when that protection fails. The history of research ethics is marked by episodes where the absence of meaningful oversight led to serious harm. Participants were deceived, exposed to dangerous substances without their knowledge, denied treatment they needed, or used as subjects without any meaningful agreement on their part. These were not isolated incidents committed by rogue scientists. Many were conducted by credentialed researchers at respected institutions, operating within the norms of their time. The Institutional Review Board system exists, in large part, because those norms were not enough.^[1]

Today, IRBs operate under a federal regulatory framework in the United States known as the Common Rule, which was first codified in 1991 and significantly revised in 2018. This framework applies to research conducted or funded by federal agencies and sets minimum standards for participant protection, including requirements for informed consent, risk assessment, and ongoing oversight. Institutions that receive federal funding must comply, which means the vast majority of universities and research hospitals are subject to IRB review for human subjects research.

The reach of IRB authority extends further than many researchers realize. A study that seems entirely benign, such as a survey asking college students about their study habits, may still require IRB review depending on how the data is collected, stored, and used. A qualitative interview study exploring sensitive personal experiences may require full-board review with extensive safeguards. The categories of review, exempt, expedited, and full-board, carry real consequences for how quickly a study can begin and what protections must be in place. Understanding these distinctions is not just a matter of compliance; it reflects genuine differences in the level of risk participants face.

IRBs also matter because they are imperfect. Critics from across the academic spectrum have argued that IRB review is inconsistent, that it applies standards designed for biomedical research poorly to social science and humanities research, that it creates unnecessary delays, and that it sometimes suppresses legitimate inquiry into sensitive but important topics. These are serious criticisms, and they deserve serious engagement. Dismissing them as the complaints of researchers who simply want less oversight misses the point. The question is not whether oversight is needed but whether the current system provides the right kind of oversight in the right way.

What makes IRBs matter, ultimately, is not just their regulatory authority but their moral function. They represent a collective decision that society has made: that the pursuit of knowledge does not justify treating people as mere instruments. That principle is worth defending. But defending it well requires understanding it deeply, including its limits, its tensions, and the ways it can be applied badly. That understanding begins with recognizing that IRBs are not neutral technical bodies. They are institutions that make value judgments, and those judgments deserve scrutiny.

The stakes are concrete. When an IRB approves a study that later harms participants, the failure is not just procedural. When an IRB blocks a study that could have generated knowledge to help vulnerable communities, that too is a failure, even if it is less visible. Both kinds of failure are real, and both matter. Holding that tension in mind is the starting point for thinking seriously about research ethics governance.

The Institutional Review Board is not the last line of defense against unethical research. It is one layer in a system that also includes researcher training, institutional culture, peer review, and professional norms. But it is the most formalized layer, and the one with the most direct authority to stop a study before it begins.

At first glance, philosophy and institutional governance seem like an odd combination. Philosophy deals in abstract principles, thought experiments, and conceptual analysis. Governance deals in rules, procedures, deadlines, and forms. Yet the two are more deeply connected than they appear, especially in the domain of research ethics. Every governance system embeds philosophical assumptions, whether or not the people running it are aware of them. IRBs are no exception.

Take the concept of informed consent. On the surface, it seems straightforward: before participating in a study, a person should be told what the study involves and should agree to participate freely. But the moment you try to implement that principle, philosophical questions multiply. What counts as adequate information? How much risk must be disclosed? What does it mean to consent freely when a participant is a student in a class taught by the researcher? What if the participant cannot fully understand the information due to age, cognitive impairment, or language barriers? Each of these questions requires a philosophical answer, even when the answer is dressed up in regulatory language.

The three major ethical frameworks that appear throughout research ethics debates are consequentialism, deontological ethics, and virtue ethics. Consequentialism evaluates actions by their outcomes: a study is ethical if its benefits outweigh its harms. Deontological ethics focuses on duties and rights: certain things are wrong regardless of their consequences, such as deceiving participants without justification. Virtue ethics asks what a person of good character would do in a given situation. IRBs draw on all three frameworks, often without explicitly acknowledging which one is driving a particular decision.

This philosophical pluralism is not a flaw. Research ethics is genuinely complex, and no single framework captures everything that matters. But the lack of explicit philosophical reasoning in IRB decision-making creates problems. When board members disagree about whether a study is ethical, they may be operating from different frameworks without realizing it. One member may be focused on the potential benefits of the research; another may be focused on the rights of participants; a third may be asking whether the researcher seems trustworthy. These are not the same question, and resolving the disagreement requires recognizing that difference.

The Belmont Report, published in 1979 by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, attempted to provide a philosophical foundation for research ethics in the United States. It identified three core principles: respect for persons, beneficence, and justice. These principles have shaped IRB practice for decades. But the Belmont Report was not a work of systematic philosophy. It was a practical document designed to guide policy, and it left many philosophical questions unresolved. The tensions among its three principles, for example, what happens when respecting a person's autonomy conflicts with protecting them from harm, are real and recurring.

Governance without philosophy tends to become mechanical. Rules are applied without understanding why they exist, and edge cases are handled inconsistently because there is no principled basis for resolving them. Philosophy without governance tends to remain abstract, generating insights that never translate into practice. The most productive approach treats them as partners. Understanding the philosophical foundations of IRB review helps researchers engage with the process more thoughtfully, helps IRB members make better decisions, and helps everyone involved recognize when the system is working well and when it is not.

One concrete example of this partnership in action is the concept of the minimal risk standard. Under the Common Rule, research that poses no more than minimal risk to participants may qualify for expedited or exempt review, bypassing the full-board process. But what counts as minimal risk? The regulatory definition refers to risks that are not greater than those ordinarily encountered in daily life. That definition sounds clear until you ask: whose daily life? A person who lives in a high-crime neighborhood faces different everyday risks than a person who lives in a safe suburb. The standard embeds an assumption about a baseline that is not philosophically neutral. Recognizing that assumption is the first step toward addressing it.

Philosophy also helps explain why IRB decisions sometimes feel arbitrary or inconsistent. Different boards at different institutions may reach different conclusions about the same study. This is partly a governance problem, a lack of standardization and training. But it is also a philosophical problem: the underlying ethical questions do not have single correct answers, and reasonable people applying the same principles in good faith can reach different conclusions. Acknowledging that does not mean abandoning the search for better answers. It means approaching that search with appropriate humility.

This book is organized to move from history and foundations toward practice and critique. Each chapter builds on the previous ones, but they are also designed to stand on their own for readers who want to focus on a particular aspect of IRB review. The progression follows a logic: you cannot evaluate a system without understanding where it came from, what principles it is built on, and how it actually operates before examining where it falls short and what alternatives might look like.

The opening chapter examines the historical events that made IRBs necessary. This is not simply a story about bad actors. It is a story about how entire research communities operated within ethical frameworks that, in retrospect, were deeply inadequate. The scandals that drove regulatory change, including the Tuskegee Syphilis Study and the experiments documented at the Nuremberg trials, were not anomalies. They were symptoms of a broader failure to take seriously the moral status of research participants. Understanding that history is essential for understanding why the current system is designed the way it is, including its strengths and its blind spots.

The philosophical foundations of research ethics are examined in depth in the following chapter. Rather than treating consequentialism, deontological ethics, and virtue ethics as competing doctrines, the book explores how they function together in practice, where they align, where they conflict, and what happens when IRB members apply them without recognizing which framework is driving their reasoning. The concept of ethical pluralism, the idea that multiple frameworks can each capture something important, is central to this discussion.

Informed consent receives its own dedicated treatment because it is both the most visible element of IRB review and the most philosophically complex. The gap between the ideal of informed consent and its real-world application is significant. Consent forms are often too long and too technical for participants to understand. The concept of autonomy that underlies consent assumes a kind of rational, independent decision-making that does not always match how people actually make choices. The phenomenon of therapeutic misconception, where research participants confuse the goals of research with the goals of clinical care, illustrates how consent can be formally obtained while remaining substantively incomplete.

The operational mechanics of IRBs, how they are structured, how they process submissions, and how they make decisions, are covered in practical detail. This includes the three categories of review and what distinguishes them, the role of the IRB chair and board members, and the criteria that boards are required to apply. Understanding these mechanics is not just useful for researchers navigating the system. It reveals the points at which philosophical assumptions are embedded in procedural requirements, often invisibly.

The book then turns to questions of power and knowledge. IRBs do not operate in a vacuum. They are embedded in institutions with their own hierarchies, politics, and interests. The concept of epistemic gatekeeping, the idea that IRBs function not just as ethical reviewers but as arbiters of what counts as legitimate research, is examined critically. This includes attention to how certain research methods, particularly qualitative and community-based approaches, have historically been treated as more problematic by IRBs designed around biomedical research norms.

The risk-benefit calculus that IRBs are required to perform is examined as both a practical challenge and a philosophical problem. Measuring and comparing risks and benefits is genuinely difficult, and the concept of incommensurability, the idea that some values simply cannot be reduced to a common scale, poses a fundamental challenge to the idea that risk-benefit analysis can be done in a rigorous, objective way. This does not mean the analysis is useless. It means it requires more honesty about its limitations than it typically receives.

The tension between protection and progress is addressed directly. The chilling effect that IRB review can have on research into sensitive topics is real and documented. The bureaucratic burden of compliance consumes researcher time and resources that could otherwise go toward the research itself. These costs are not trivial, and they fall unevenly across disciplines and institutions. At the same time, the alternative to meaningful oversight is not a frictionless research environment. It is a return to the conditions that made IRBs necessary in the first place.

Special cases and emerging challenges occupy a significant portion of the later chapters. Qualitative research ethics raises questions that standard IRB frameworks handle poorly, including the ethics of researcher positionality, the challenge of maintaining confidentiality in small communities, and the difficulty of specifying in advance exactly what an interview study will involve. Digital research ethics is an area where the regulatory framework has not kept pace with practice: questions about whether online behavior constitutes public or private data, whether scraping social media posts requires consent, and how to protect participants in anonymous online communities do not have settled answers. Community-based participatory research challenges the assumption that the researcher is the primary decision-maker about what is ethical, proposing instead that communities themselves should have meaningful authority over research that affects them.

The final chapters engage with scholarly critiques of the IRB system and the alternative governance models that have been proposed or piloted. These range from discipline-specific ethics review processes to community-based oversight structures to more flexible, reflexive ethics approaches that emphasize ongoing ethical reflection rather than front-loaded compliance. None of these alternatives is without its own problems, but engaging with them seriously is necessary for thinking about how research ethics governance might evolve.

Throughout, the book uses concrete examples to ground abstract concepts. These examples are drawn from real research contexts: the kinds of studies that researchers actually conduct, the kinds of decisions that IRBs actually face, and the kinds of dilemmas that arise when principles meet practice. The goal is not to provide a compliance manual. It is to develop the conceptual tools needed to think critically and carefully about one of the most consequential but least examined institutions in academic life. The researcher frustrated by her IRB's requests, and the IRB members who made them, both deserve a framework for understanding what they are actually arguing about. That framework is what this book aims to provide.